Bright light, better mood? glasses that mimic morning sun tested for depression on dialysis

NCT ID NCT07729358

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether light therapy glasses can reduce depression in people with end-stage kidney disease who undergo hemodialysis three times a week. Participants wear either active glasses (1000 lux) or a sham device (50 lux) for 30 minutes each session over five weeks. The goal is to see if morning light exposure improves mood and sleep quality without medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
light therapy using active glasses (Luminette3) emitting 1000 lux
What this could lead to
If effective, light therapy could offer a drug-free way to ease depression and improve sleep in people undergoing kidney dialysis.
What could go wrong
This is a relatively small, early-stage trial. The sham device also emits some light (50 lux), which may reduce the difference between groups. Light therapy may not work for everyone and requires consistent use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Annecy Genevois

    Annecy, 74370, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.